8:10 am – 8:14 am Impact of mindfulness practices on the quality of life of women with breast cancer: systematic review
Paulo Gustavo Tenório do Amaral (BRA)
8:14 am – 8:18 am Epigenetic modulation of 3D telomeric architecture by 5-aza-dc in luminal and triple-negative breast cancer cells
Fábio Morato de Oliveira (BRA)
8:18 am – 8:22 am Immediate breast reconstruction using a latissimus dorsi flap: Is lipofilling or implant-based reconstruction better?
Andrea Pires Souto Damin (BRA)
8:22 am – 8:26 am Impact of short-duration physical exercise on the upper limb of women treated for breast cancer. blue flower project
Daniel Buttros (BRA)
8:26 am – 8:30 am The effects of resistance training vs. combined training on the health-related quality of life levels of breast cancer patients undergoing neoadjuvant chemotherapy
Anderson Garcia Silva (BRA)
8:30 am – 8:40 am Discussion
8:40 am – 9:10 am Mini conference: General issue: impacts of chemotherapy on the indicators of body composition, comorbidities and exercise practice of women undergoing breast cancer treatment
Carlos Alexandre Vieira (BRA)
Chairman
10’ Impact of chemotherapy regimens on body composition of breast cancer women: a multicenter study across four Brazilian regions
Jordana Carolina Marques Godinho Mota (BRA)
Speaker
10’ Effects of supervised movement on comorbidities associated with chemotherapy
Nayara Alves de Freitas Lemos (BRA)
Speaker
10’ Insights on strength training, during chemotherapy treatment, for breast cancer
Rafael Ribeiro Alves (BRA)
Speaker
9:10 am – 9:40 am Satellite Symposium – Knight: Effective strategies for controlling nausea and vomiting in the face of new cancer treatments
Andreza Karine de Barros Almeida Souto (BRA)
9:40 am – 10:30 am Coffee Break
Fast presentation 2
10:30 am – 11 am
Carlos Alexandre Vieira (BRA)
Coordinator
Marcelo Antonini (BRA)
Discussants
Marise Amaral Rebouças Moreira (BRA)
Discussants
10:30 am – 10:34 am
Utilizing machine learning to identify biomarkers of chemoresistance in breast cancer: a complementary analysis with in vitro resistance platforms
Martina Lichtenfels (BRA)
10:34 am – 10:38 am
Efficacy and safety of capivasertib for breast cancer patients: a systematic review and meta-analysis of randomized controlled trials
Valbert Oliveira Costa Filho (BRA)
10:38 am – 10:42 am
The role of liquid biopsy in breast cancer screening and monitoring: a systematic review of literature
Vyvian Paes de Oliveira (BRA)
10:42 am – 10:46 am
Evaluation of the impact and evolution of community health agents (CHAs) in early breast cancer detection in the Itaberaí Project, Goiás
Christina Souto Cavalcante Costa (BRA)
10:46 am – 10:50 am
Stage I HER2-positive breast cancer - is systemic therapy required?
Renata Rodrigues da Cunha Colombo Bonadio (BRA)
10:50 am – 11 am Discussion
11 am – 11:20 am Mini conference: Leadership in healthcare: in an increasingly challenging scenario, necessary and understandable knowledge
Cícero de Andrade Urban (BRA)
Chairman
Max S. Mano (BRA)
Speaker
11:20 am – 11:30 am Discussion
11:30 am – 11:50 am Mini conference: Genetic signature: beyond risk stratification
Alexandre Marchiori Xavier de Jesus (BRA)
Chairman
Fábio Postiglione Mansani (BRA)
Speaker
11:50 pm – 12 pm Discussion
12 pm – 2 pm Lunch
Fast presentation 3
2 pm – 2:30 pm
Marcus Nascimento Borges (BRA)
Coordinator
Giuliano Mendes Duarte (BRA)
Discussants
Luis Fernando Pádua Oliveira (BRA)
Discussants
2 pm – 2:04 pm Prognostic impact of real-world immunohistochemical changes in breast cancer treated with neoadjuvant chemotherapy
Marcelo Antonini (BRA)
2:04 pm – 2:08 pm Progression-free survival as a surrogate endpoint for overall survival in antibody-drug conjugate trials for advanced breast cancer: a systematic review and meta-analysis
Anelise Poluboiarinov Cappellaro (BRA)
2:08 pm – 2:12 pm MicroRNA-21 (miR-21) expression and its association with resistance to neoadjuvant chemotherapy in breast cancer: preliminary results
Andrea Pires Souto Damin (BRA)
2:12 pm – 2:16 pm Immune-related adverse events among patients with early-stage triple-negative breast cancer treated with pembrolizumab plus chemotherapy: real-world data from the Neo-Real/GBECAM 0123 study
Matheus de Oliveira Andrade (BRA)
2:16 pm – 2:20 pm Grade 1 hormone receptor-positive early breast cancer – is oncotype dx necessary?
Renata Rodrigues da Cunha Colombo Bonadio (BRA)
2:20 pm – 2:30 pm Discussion
2:30 pm – 2:50 pm Mini conference: Hormone replacement therapy / hormonal implants: indications and contraindications
Érika Pereira de Sousa e Silva (BRA)
Chairwoman
João Bosco Ramos Borges (BRA)
Speaker
2:50 pm – 3 pm Discussion
Fast presentation 4
3 pm – 3:30 pm
Rafael Henrique Szymanski Machado (BRA)
Coordinator
Maria Alves Barbosa (BRA)
Discussants
Luiz de Paula Silveira Júnior (BRA)
Discussants
3 pm – 3:04 pm Genetic screening of pathogenic variants in relatives of patients with hereditary breast and ovarian cancer in the state of Goiás: tool for early diagnosis and prevention of breast and ovarian cancer in the Goiás Todo Rosa Program
Elisângela de Paula Silveira Lacerda (BRA)
3:04 pm – 3:08 pm Omission of axillary lymph node dissection in clinically node-negative breast cancer with sentinel node metastasis: a systematic review and meta-analysis of noninferiority randomized clinical trials
Maria Clara Ramos Miranda (BRA)
3:08 pm – 3:12 pm A Comprehensive meta-analysis and systematic review of same-day discharge protocols following mastectomy with immediate breast reconstruction in surgical oncology
Luana Ferreira Vasques (BRA)
3:12 pm – 3:16 pm Identifying predictors of implant loss in immediate breast reconstruction: integrating surgical and dosimetric factors in a large-scale study
Dayane Innocente Souza (BRA)
3:16 pm – 3:20 pm Osteoradionecrosis/osteomyelitis of the chest wall associated with radiotherapy for breast cancer
René Aloisio da Costa Vieira (BRA)
3:20 pm – 3:30 pm Discussion
3:30 pm – 3:50 pm Mini conference: Management of Keynote-522 in clinical practice, post-KN522 adjuvant strategy and pathways for de-escalation
Tatiana Strava Correa (BRA)
Chairwoman
Renata Rodrigues da Cunha Colombo Bonadio (BRA)
Speaker
3:50 pm – 4 pm Discussion
4 pm – 4:30 pm Coffee Break
4:30 pm – 4:50 pm Mini conference: The woman in menopause: before, during and after cancer
Katyane Larissa Alves (BRA)
Chairwoman
Daniel Buttros (BRA)
Speaker
4:50 pm – 5 pm Discussion
5 pm – 5:20 pm Mini conference: Cryoablation in breast cancer: from ANVISA approval to clinical practice - are we ready?
Daniel Meirelles Barbalho (BRA)
Chairman
Silvio Bromberg (BRA)
Speaker
5:20 pm – 5:30 pm Discussion
5:30 pm – 5:50 pm Mini conference: Tumour microenvironment role on the behaviour of breast cancer
